@Article{Piotrowski2021,
journal="Alergologia Polska - Polish Journal of Allergology",
issn="2353-3854",
volume="8",
number="3",
year="2021",
title="Statement of Polish Respiratory Society and Polish Society 
of Allergology on the treatment of pulmonary complications 
in patients after SARS-CoV-2 infection",
abstract="The aim of this document is to provide physicians treating patients with a history of COVID-19 pneumonia with recommendations on proper diagnostics and management of respiratory sequelae associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The expert panel provides 32 recommendations with respect to the treatment of lung consequences (including antibiotic therapy, corticosteroid therapy, and antithrombotic prophylaxis and treatment), pulmonary rehabilitation, lung transplantation, patient monitoring, and ambulatory settings. The management of patients with respiratory comorbidities (asthma, chronic obstructive pulmonary disease, lung cancer, and interstitial lung disease) and the medications used for treatment of these conditions, such as corticosteroids and antifibrotic drugs, is discussed. Presented recommendations are based on the most recent reports and aimed at providing patients post-COVID-19 respiratory sequelae with optimal standards of care.",
author="Piotrowski, Wojciech J.
and Barczyk, Adam
and Chciałowski, Andrzej
and Chorostowska-Wynimko, Joanna
and Czajkowska-Malinowska, Małgorzata
and Kania, Aleksander
and Kupczyk, Maciej
and Sładek, Krzysztof
and Kulus, Marek
and Śliwiński, Paweł",
pages="101--129",
doi="10.5114/pja.2021.109379",
url="http://dx.doi.org/10.5114/pja.2021.109379"
}